netFormulary Kettering General Hospital NHS
NHS Foundation Trust  
 Search
 Formulary Chapter 10: Musculoskeletal and joint diseases - Full Chapter
10.01.03  Expand sub section  Drugs which suppress the rheumatic disease process
10.01.03  Expand sub section  Gold
10.01.03  Expand sub section  Penicillamine
10.01.03  Expand sub section  Antimalarials
10.01.03  Expand sub section  Drugs affecting the immune response to top
Abatacept (Orencia)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red
 
Link  NICE TA195: Rheumatoid arthritis - drugs for treatment after failure of a TNF inhibitor
Link  NICE TA280: Rheumatoid arthritis - abatacept (2nd line)
   
Adalimumab (Humira)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red
Injection 40mg/0.8ml 
Link  NICE TA130: Rheumatoid arthritis - adalimumab, etanercept and infliximab
Link  NICE TA195: Rheumatoid arthritis - drugs for treatment after failure of a TNF inhibitor
Link  NICE TA383: TNF-alpha inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis
   
Anakinra (Kineret)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted Injection 100mg/0.67ml 
   
Azathioprine
View adult BNF View SPC online View childrens BNF
Formulary
Amber 1
Tablets 25mg and 50mg 
   
Baricitinib tablets (Olumiant®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red
High Cost Medicine
-2mg and 4mg tablets 
Link  NICE TA466: Baricitinib for moderate to severe rheumatoid arthritis
   
Brodalumab 210mg/1.5ml solution for injection pre-filled syringes  (Kyntheum)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
CCG
 
Link  NICE TA511: Brodalumab for treating moderate to severe plaque psoriasis
   
Certolizumab Pegol Injection 200mg (Cimzia)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red
 
Link  NICE TA186: Rheumatoid arthritis - certolizumab pegol
Link  NICE TA574: Certolizumab pegol for treating moderate to severe plaque psoriasis
Link  NICE: TA383 TNF-alpha inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis
Link  NICE TA415:Certolizumab pegol for treating rheumatoid arthritis after inadequate response to a TNF-alpha inhibitor
Link  NICE TA445: Certolizumab pegol and secukinumab for treating active psoriatic arthritis after inadequate response to DMARDs
   
Ciclosporin
View adult BNF View SPC online View childrens BNF
Formulary
Amber 1
Capsules 25mg, 50mg and 100mg
Oral solution 100mg/ml
Concentrate for infusion 50mg/ml 
   
Dupilumab (Dupixent)
View adult BNF View SPC online View childrens BNF
Formulary  
Link  NICE TA534: Dupilumab for treating moderate to severe atopic dermatitis
   
Etanercept (Enbrel)
View adult BNF View SPC online View childrens BNF
Formulary
Red
Injection 50mg 
Link  NICE TA130: Rheumatoid arthritis - adalimumab, etanercept and infliximab
Link  NICE TA195: Rheumatoid arthritis - drugs for treatment after failure of a TNF inhibitor
Link  NICE TA383: TNF-alpha inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis
   
Infliximab (Remicade)
View adult BNF View SPC online View childrens BNF
Formulary
Amber 1
Infusion 100mg 
Link  NICE TA130: Rheumatoid arthritis - adalimumab, etanercept and infliximab
Link  NICE TA134: Psoriasis - infliximab
Link  NICE TA195: Rheumatoid arthritis - drugs for treatment after failure of a TNF inhibitor
Link  NICE TA383: TNF-alpha inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis
   
Leflunomide (Arava)
View adult BNF View SPC online View childrens BNF
Formulary
Amber 1
Tablets 10mg, 20mg and 100mg 
   
Methotrexate (Metoject)
View adult BNF View SPC online View childrens BNF
Formulary
Red
Pre-filled pens: 7.5mg, 10mg, 12.5mg, 15mg, 17.5mg, 20mg, 22.5mg and 25mg 
   
Cytotoxic Drug Methotrexate tablets 2.5mg
View adult BNF View SPC online View childrens BNF
Formulary
Amber 1
For rheumatology indications and myasthenia gravis. For other indications, see relevant chapters.
 
   
Risankizumab (Skyrizi)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted  
Link  NICE TA596: Risankizumab for treating moderate to severe plaque psoriasis
   
Rituximab (MabThera)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Red
 
Link  NICE TA195: Rheumatoid arthritis - drugs for treatment after failure of a TNF inhibitor
Link  NICE TA308: Vasculitis (anti-neutrophil cytoplasmic antibody-associated) - rituximab (with glucocorticoids)
   
Tocilizumab (RoActemra)
View adult BNF View SPC online View childrens BNF
Formulary
Red
Infusion 80mg/4ml 
Link  NICE TA238: Arthritis (juvenile idiopathic, systemic) - tocilizumab
Link  NICE TA247: Rheumatoid arthritis - tocilizumab
Link  NICE TA518: Tocilizumab for treating giant cell arteritis
   
10.01.03  Expand sub section  Cytokine modulators
10.01.03  Expand sub section  Sulfasalazine
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Amber 1

"Amber 1" - These are medicines that require significant monitoring and the decision to treat with an AMBER medicine should be made by specialists only  

Amber 2

"Amber 2" - These are medicines that require little or no monitoring by the GP, but should only be prescribed in general practice after they have been recommended following specialist referral.  

Red

"Red" - Secondary care only  

RedRed

"Double Red" - NOT recommended for prescribing in either primary or secondary care  

Grey

Traffic light status to be confirmed  

Green

May be prescribed in primary and secondary care  

netFormulary